Research ArticleArticle
The Relative Activity of “Function Sparing” HIV-1 Entry Inhibitors on Viral Entry and CCR5 Internalization: Is Allosteric Functional Selectivity a Valuable Therapeutic Property?
Vanessa M. Muniz-Medina, Stacey Jones, Jodi M. Maglich, Cristin Galardi, Robert E. Hollingsworth, Wieslaw M. Kazmierski, Robert G. Ferris, Mark P. Edelstein, Karen E. Chiswell and Terry P. Kenakin
Molecular Pharmacology March 2009, 75 (3) 490-501; DOI: https://doi.org/10.1124/mol.108.052555
Vanessa M. Muniz-Medina
Stacey Jones
Jodi M. Maglich
Cristin Galardi
Robert E. Hollingsworth
Wieslaw M. Kazmierski
Robert G. Ferris
Mark P. Edelstein
Karen E. Chiswell
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
The Relative Activity of “Function Sparing” HIV-1 Entry Inhibitors on Viral Entry and CCR5 Internalization: Is Allosteric Functional Selectivity a Valuable Therapeutic Property?
Vanessa M. Muniz-Medina, Stacey Jones, Jodi M. Maglich, Cristin Galardi, Robert E. Hollingsworth, Wieslaw M. Kazmierski, Robert G. Ferris, Mark P. Edelstein, Karen E. Chiswell and Terry P. Kenakin
Molecular Pharmacology March 1, 2009, 75 (3) 490-501; DOI: https://doi.org/10.1124/mol.108.052555
Research ArticleArticle
The Relative Activity of “Function Sparing” HIV-1 Entry Inhibitors on Viral Entry and CCR5 Internalization: Is Allosteric Functional Selectivity a Valuable Therapeutic Property?
Vanessa M. Muniz-Medina, Stacey Jones, Jodi M. Maglich, Cristin Galardi, Robert E. Hollingsworth, Wieslaw M. Kazmierski, Robert G. Ferris, Mark P. Edelstein, Karen E. Chiswell and Terry P. Kenakin
Molecular Pharmacology March 1, 2009, 75 (3) 490-501; DOI: https://doi.org/10.1124/mol.108.052555
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement